Sarah Burack represents clients in complex commercial litigations and arbitrations and advises on pre-dispute communications and strategy.

Sarah leverages sophisticated technical knowledge and extensive experience to represent companies and individuals in disputes across multiple sectors, including:

  • Financial
  • Technology
  • Biopharmaceuticals

She has successfully tried numerous cases to verdict in state and federal courts and in international and domestic arbitrations.

A recognized leader at the firm, Sarah sits on Latham’s Technology Committee and previously sat on the firm’s Associates Committee. She maintains an active pro bono practice focused on impact litigation and policy advice.

Sarah's recent experience includes representation of:

  • A consumer product company in successful JAMS arbitration in a dispute with its supplier over contract performance and termination, resulting in a multimillion damages award for our client and the dismissal of more than US$500 million in counterclaims
  • A technology company in a breach of contract dispute in federal court, resulting in a US$26 million jury verdict
  • A Fortune 500 technology company in a post-M&A dispute arbitration, successfully defeating a US$1 billion claim and winning a full US$70 million counterclaim after trial
  • A hedge fund in an international investment dispute against the government of Korea, alleging losses sustained due to the state’s wrongful conduct, resulting in a successful multimillion US dollar verdict
  • A NYSE-listed biopharmaceutical developer in two complex arbitrations and ongoing related civil litigations related to various development and licensing agreements
  • A global NYSE-listed financial technology company in an ongoing insurance arbitration
  • A medical device manufacturer in a post-M&A dispute over milestone payments, resulting in a US$60 million arbitration award
  • A global public software company in a Philadelphia state court action against a supplier relating to the licensing of educational software for the client’s software platform; resulted in the entry of summary judgment in the client’s favor and dismissing the supplier’s principal breach of contract claim for over US$500 million
  • A financial technology company in a successful commercial arbitration arising from a development deal
  • A global chemicals company in chapter 11 bankruptcy adversary proceedings in the Southern District of Texas related to prior liability management transactions (ongoing)
  • The principals of a technology startup in litigation with their former employer in the Southern District of New York, resulting in dismissal of the former employer’s bid for PI relief (ongoing)
  • A cryptocurrency investment fund and its principals in an ongoing dispute alleging breaches of fiduciary duty in the Delaware Court of Chancery (ongoing)

Bar Qualification

  • New York

Education

  • JD, Yale Law School
  • M.Phil., University of Cambridge
  • BA, Harvard University

Languages Spoken

  • English
Light Christmas Golden Luxury Glitter Background.
March 9, 2026 Recognition

Top Verdict: Homyk v. ChemoCentryx Inc.

California’s Daily Journal spotlights Latham team who won a landmark summary judgment victory for client Amgen in a securities class action.